Somatostatin analog RC-160 inhibits the growth of human osteosarcomas in nude mice

International Journal of Cancer

Volumn 65, Issue 6, 1996, Pages 870-874

  Pinski, Jacek ^a,b   Schally, Andrew V ^a,b   Halmos, Gabor ^a,b   Szepeshazi, Karoly ^a,b   Groot, Kate ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; VAPREOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; OSTEOSARCOMA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR XENOGRAFT;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CELL DIVISION; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; OSTEOSARCOMA; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, IGF TYPE 1; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; TUMOR CELLS, CULTURED;

EID: 0029918743     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960315)65:6<870::AID-IJC27>3.0.CO;2-6     Document Type: Article

References (25)

1. BELL, G.I. and REISINE, T., Molecular biology of somatostatin receptors. Trends Neurosci., 1, 34-38 (1993).
2. BLOOM, E.T., Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture. Cancer Res., 32, 960-967 (1972).
3. BREIER, B.H., GALLAHER, B.W. and GLUCKMAN, P.D., Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfalls. J. Endocrinol., 128, 347-357 (1991).
4. BUSCAIL, L., DELESQUE, N., ESTEVE, J.-P., SAINT-LAURENT, N., PRATS, H., CLERC, P., ROBBERECHT, P., BELL, G.I., LIEBOW, C., SCHALLY, A.V., VAYSSE, N. and SUSINI, C., Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc. nat. Acad. Sci. (Wash.), 91, 2315-2319 (1994).
5. FOURNIER, B., FERRALLI, J.M., PRICE, P.A. and SCHLAEPPI, J.M., Comparison of the effects of insulin-like growth factors-I and -II on the human osteosarcoma cell line OHS-4. J. Endocrinol., 136, 173-180 (1993).
6. KAPPEL, C.C., VELEZ-YANGUAS, M.C., HIRSCHFELD, S. and HELMAN, L.J., Human osteosarcoma cell lines are dependent on insulin-like growth factor I in vitro growth. Cancer Res., 54, 2803-2807 (1994).
7. LIEBOW, C., REILLY, C., SERRANO, M. and SCHALLY, A.V., Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine-phosphatase. Proc. nat. Acad. Sci. (Wash.), 86, 2003-2007 (1989).
8. LOPACZYNSKI, W., HARRIS, S. and NISSLEY, P., Insulin-like growth factor-I (IGF-I) dependent phosphorylation of the IGF-I receptor in MG-63 cells. Regul. Peptides, 48, 207-216 (1993).
9. MUNSON, P.J. and RODBARD, D., Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem., 107, 220-239 (1980).
10. O'BYRNE, K.J., HALMOS, G., PINSKI, J., GROOT, K., SZEPESHAZI, K., SCHALLY, A.V. and CARNEY, D.N., Somatostin receptor expression in lung cancer. Europ. J. Cancer, 30A, 1682-1687 (1994).
11. PINSKI, J., HALMOS, G., YANO, T., SZEPESHAZI, K., QIN, Y., ERTL, T. and SCHALLY, A.V., Inhibition of growth of MKN45 human gastriccarcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160. Int. J. Cancer, 57, 574-580 (1994).
12. PIRSKANEN, A., JAASKELAINEN, T. and MAENPAA, P.H., Insulin-like growth factor-I modulates steroid hormone effects on osteocalcin synthesis in human MG-63 osteosarcoma cells. Europ J. Biochem., 218, 883-891 (1993).
13. POLLAK, M.N., POLYCHRONAKOS, C. and GUYDA, H., Somatostatin analogue SMS 201-995 reduces serum IGF-I levels in patients with neoplasm potentially dependent on IGF-I. Anticancer Res., 9, 889-891 (1989).
14. POLLAK, M.N., POLYCHRONAKOS, C. and RICHARD, M., Insulin-like growth factor I: a potent mitogen for human osteogenic sarcoma. J. nat. Cancer Inst., 82, 301-305 (1990).
15. POLLAK, M., SEM, A.W., RICHARD, M., TETENES, E. and BELL, R., Inhibition of metastatic behavior of murine osteosarcoma by hypophysectomy. J. nat Cancer Inst., 84, 966-971 (1992).
16. RAILE, K., HOFLICH, A., KESSLER, U., YANG, Y., PFUENDER, M., BLUM, W.F., KOLB, H., SCHWARZ, H.P. and KIESS, W., Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor. J. cell. Physiol., 159, 531-541 (1994).
17. REDDING, T.W. and SCHALLY, A.V., Inhibition of growth of transplantable rat chondrosarcoma by analogs of hypothalamic hormones. Proc nat. Acad. Sci. (Wash.), 80, 1078-1082 (1983).
18. REUBI, J., A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth. Acta Endocrinol., 109, 108-114 (1985).
19. RHIM, J.S., PARK, D.K., ARNSTEIN, P., HUEBNER, R.J., WEISBURGER, E.K. and NELSON-REES, W.A., Transformation of human cells in culture by N-methyl-N'-nitro-N-nitrosoguanidine. Nature (Lond.), 256, 751-753 (1975).
20. ROSEN, G., Bone tumors, In. J.F. Holland, E. Frei, R.C. Bast, D.W. Kufe, D.L. Morton and R.R. Weichselbaum (eds.), Cancer medicine (3rd ed.), vol. 2, pp. 1825-1858, Lea and Febiger, Philadelphia (1993).
21. SCHALLY, A.V., Oncological applications of somatostatin analogs. Cancer Res., 48, 6977-6985 (1988).
22. SCHEVEN, B.A.A., HAMILTON, N.J., FAKKELDIJ, T.M.V. and DUURSMA, S.A., Effects of recombinant human insulin-like growth factor-I and II (IGF-I/II) and growth hormone (GH) on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells Growth Regul., 1, 160-167 (1991).
23. SRKALOVIC, G., SZENDE, B., REDDING, T.W., GROOT, K. and SCHALLY, A.V., Receptors for D-Trp-6-luteinizing hormone-releasing hormone, somatostatin and insulin-like growth factor I in MXT mouse mammary carcinoma. Proc. Soc. exp. Biol. Med., 192, 209-218 (1989).
24. STEEL, R.G.D. and TORRIE, J., Principles and procedures of statistics, p. 114, McGraw-Hill, New York (1960).
25. SZEPESHAZI, K., SCHALLY, A.V., HALMOS, H., GROOT, K. and RADULOVIC, S., Antagonist of bombesin/gastrin-releasing peptide inhibits growth of estrogen dependent and independent MXT mammary cancers in mice. J. nat. Cancer Inst , 84, 1915-1921 (1992).